BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27324298)

  • 21. Parotid metastatic disease from cutaneous squamous cell carcinoma: prognostic role of facial nerve sacrifice, lateral temporal bone resection, immune status and P-stage.
    Shao A; Wong DK; McIvor NP; Mylnarek AM; Chaplin JM; Izzard ME; Patel RS; Morton RP
    Head Neck; 2014 Apr; 36(4):545-50. PubMed ID: 23780509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Better outcome for parotid versus neck metastasis of head and neck cutaneous squamous cell carcinoma: a new report on reemerging data.
    Girardi FM; Wagner VP; Martins MD; Abentroth AL; Hauth LA
    Braz J Otorhinolaryngol; 2021; 87(4):389-395. PubMed ID: 31870740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of nodal metastatic cutaneous squamous cell carcinoma of the head and neck treated in a regional center.
    Schmidt C; Martin JM; Khoo E; Plank A; Grigg R
    Head Neck; 2015 Dec; 37(12):1808-15. PubMed ID: 24995842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Total Parotidectomy for Metastatic Cutaneous Squamous Cell Carcinoma and Malignant Melanoma.
    Thom JJ; Moore EJ; Price DL; Kasperbauer JL; Starkman SJ; Olsen KD
    JAMA Otolaryngol Head Neck Surg; 2014 Jun; 140(6):548-54. PubMed ID: 24722863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N1S3: a revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: results of 2 Australian Cancer Centers.
    Forest VI; Clark JJ; Veness MJ; Milross C
    Cancer; 2010 Mar; 116(5):1298-304. PubMed ID: 20052712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metastatic cutaneous squamous cell carcinoma to parotid nodes: the role of bolus with adjuvant radiotherapy.
    Pramana A; Browne L; Graham PH
    J Med Imaging Radiat Oncol; 2012 Feb; 56(1):100-8. PubMed ID: 22339753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting survival and locoregional control in head and neck cSCCA with nodal metastasis.
    Creighton F; Lin A; Leavitt E; Lin D; Deschler D; Emerick K
    Laryngoscope; 2018 Aug; 128(8):1881-1886. PubMed ID: 29266236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rate of regional nodal metastases of cutaneous squamous cell carcinoma in the immunosuppressed patient.
    McLaughlin EJ; Miller L; Shin TM; Sobanko JF; Cannady SB; Miller CJ; Newman JG
    Am J Otolaryngol; 2017; 38(3):325-328. PubMed ID: 28202188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of lymph node metastasis of parotid cancer.
    Shinomiya H; Otsuki N; Yamashita D; Nibu K
    Auris Nasus Larynx; 2016 Aug; 43(4):446-50. PubMed ID: 26656731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metastatic cutaneous squamous cell carcinoma to the parotid and cervical lymph nodes: treatment and outcomes.
    Bumpous J
    Curr Opin Otolaryngol Head Neck Surg; 2009 Apr; 17(2):122-5. PubMed ID: 19346945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nodal metastasis size predicts disease-free survival in cutaneous head and neck squamous cell carcinoma involving the parotid but not cervical nodes.
    Sood A; Wykes J; McGuinness J; Fowler A; Ebrahimi A
    ANZ J Surg; 2020 Dec; 90(12):2537-2542. PubMed ID: 33176051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymph node ratio as a prognostic factor in metastatic cutaneous head and neck squamous cell carcinoma.
    Vasan K; Low TH; Gupta R; Ashford B; Asher R; Gao K; Ch'ng S; Palme CE; Clark JR
    Head Neck; 2018 May; 40(5):993-999. PubMed ID: 29360276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metastatic cutaneous squamous cell carcinoma of the parotid gland: prognostic factors.
    Coombs AC; Butler A; Allison R
    J Laryngol Otol; 2018 Mar; 132(3):264-269. PubMed ID: 28677515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Staging cutaneous squamous cell carcinoma metastases to the parotid gland.
    Czerwonka L; De Santis RJ; Horowitz G; Hong M; Orsini M; Enepekides D; Goldstein DP; Dort J; Higgins K
    Laryngoscope; 2017 Sep; 127(9):2063-2069. PubMed ID: 28295401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcomes and quality of life of 186 patients with primary parotid carcinoma treated with surgery and radiotherapy at the Daniel den Hoed Cancer Center.
    Al-Mamgani A; van Rooij P; Verduijn GM; Meeuwis CA; Levendag PC
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):189-95. PubMed ID: 22330990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parotidectomy and neck dissection in locally advanced and relapsed cutaneous squamous cell carcinoma of the head and neck region.
    Melo GM; Guilherme LH; Palumbo MDN; Rosano M; Neves MCD; Callegari FM; Abrahao M; Cervantes O
    Braz J Otorhinolaryngol; 2022; 88 Suppl 4(Suppl 4):S152-S162. PubMed ID: 35042657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of Parotid Metastatic Cutaneous Squamous Cell Carcinoma: Regional Recurrence Rates and Survival.
    Hirshoren N; Ruskin O; McDowell LJ; Magarey M; Kleid S; Dixon BJ
    Otolaryngol Head Neck Surg; 2018 Aug; 159(2):293-299. PubMed ID: 29533706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of disease-free interval in head and neck cutaneous squamous cell carcinoma with nodal metastases.
    Ebrahimi A; Clark JR; Ahmadi N; Palme CE; Morgan GJ; Veness MJ
    Head Neck; 2013 Aug; 35(8):1138-43. PubMed ID: 23152126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary and metastatic cancer of the parotid: comparison of clinical behavior in 232 cases.
    Bron LP; Traynor SJ; McNeil EB; O'Brien CJ
    Laryngoscope; 2003 Jun; 113(6):1070-5. PubMed ID: 12782825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase III randomized trial of preoperative concurrent chemoradiotherapy versus preoperative radiotherapy for patients with locally advanced head and neck squamous cell carcinoma.
    Yi J; Huang X; Xu Z; Liu S; Wang X; He X; Luo D; Luo J; Xiao J; Zhang S; Wang K; Qu Y; Tang Y; Liu W; Xu G; Gao L; Wang D
    Oncotarget; 2017 Jul; 8(27):44842-44850. PubMed ID: 28179586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.